Finally, ATMi pre-treatment resulted in the attenuation of the CX-5461 response in both cell lines, suggesting that ATM-dependent signaling potentiates the tumor-killing mechanism of CX-5461 irrespective of the Top2α status (Figure 2E). Here, TOP2A is linked to neoplasm.